Novo Nordisk A/S (NVO)
38.56
+0.06
(+0.16%)
USD |
NYSE |
Mar 05, 13:19
Novo Nordisk Price : 38.56 for March 5, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascendis Pharma A/S | 236.92 |
| Evaxion AS | 3.15 |
| Regeneron Pharmaceuticals, Inc. | 762.09 |
| Viking Therapeutics, Inc. | 30.40 |
| DBV Technologies SA | 21.40 |
Price Related Metrics
| PE Ratio | 11.12 |
| PS Ratio | 3.672 |
| PEG Ratio | 1.969 |
| Price to Book Value | 7.409 |
| Price to Free Cash Flow | 39.00 |
| Earnings Yield | 8.99% |
| Market Cap | 171.39B |
| PEGY Ratio | 1.097 |
| Operating PE Ratio | 8.918 |
| Normalized PE Ratio | 11.12 |